Vitrolife Interim Report January-March 2005
10 mai 2005 04h05 HE
|
Vitrolife
STOCKHOLM, Sweden, May 10, 2005 (PRIMEZONE) -- Vitrolife:
-- Sales increased by 3 percent, to SEK 30.5 (29.5) million. Adjusted
for exchange-rate effects the increase was 6 percent.
--...
Notice to attend the Annual General Meeting of Vitrolife AB
06 avr. 2005 10h18 HE
|
Vitrolife
STOCKHOLM, Sweden, April 6, 2005 (PRIMEZONE) -- The shareholders of Vitrolife AB (publ) are hereby invited to the Annual General Meeting of shareholders on Tuesday May 10, 2005 at 5 pm on the...
Annual report 2004 Vitrolife AB (publ)
04 avr. 2005 03h04 HE
|
Vitrolife
STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Vitrolife's annual report (in Swedish) has now been published and can be downloaded as a pdf file, either through the link below or from...
Report on Operations 2004: Vitrolife Doubles Operating Income
21 févr. 2005 02h50 HE
|
Vitrolife
STOCKHOLM, Sweden, Feb. 21, 2005 (PRIMEZONE) -- Vitrolife:
- Sales increased by 8 percent, to SEK 103.9 (96.3) million. Adjusted for exchange-rate effects the increase was 11 percent. During the...
Vitrolife Obtains Patent in USA
15 févr. 2005 05h54 HE
|
Vitrolife
STOCKHOLM, Sweden, Feb. 15, 2005 (PRIMEZONE) -- Vitrolife has been informed that the company's patent application regarding the use of alanyl-glutamine in media for in vitro fertilization has been...
Nominations Committee for Vitrolife AB (publ)
07 févr. 2005 09h36 HE
|
Vitrolife
STOCKHOLM, Sweden, Feb. 07, 2005 (PRIMEZONE) -- The following people have been appointed as members of Vitrolife's nominations committee for the Annual General Meeting in 2005:
Carl Rosen,...
Vitrolife Receives Product Approval in USA
27 janv. 2005 08h25 HE
|
Vitrolife
STOCKHOLM, Sweden, Jan. 27, 2005 (PRIMEZONE) -- Vitrolife has received sales approval from the Food and Drug Administration (FDA) to start marketing of its product ICSI(TM). The product is the first...
Vitrolife Interim Report January -- September 2004
28 oct. 2004 07h58 HE
|
Vitrolife
STOCKHOLM, Sweden, Oct. 28, 2004 (PRIMEZONE) -- Vitrolife:
- Sales increased by 10 percent, to SEK 79.3 (72.3) million. Adjusted for exchange-rate effects the increase was 13 percent. During the...
Vitrolife Signs Research Agreement With Dr. Peter Svalander
20 oct. 2004 08h58 HE
|
Vitrolife
STOCKHOLM, Sweden, Oct. 20, 2004 (PRIMEZONE) -- Vitrolife has signed a research agreement with Dr. Peter Svalander, the founder and former CEO of the company, regarding product development within the...
Vitrolife Strengthens Its Sales And Marketing Organization
08 oct. 2004 09h48 HE
|
Vitrolife
STOCKHOLM, Sweden, Oct. 8, 2004 (PRIMEZONE) -- Vitrolife has strengthened its sales and marketing organization with Christer de Flon, the new sales director, and Roy Vallie, the new sales manager in...